PPARG and neoplasm: Contrastingly, it was reported that the low dosage of PPARγ ligand 15-d Δ PGJ2 and pioglitazone promoted cell growth and tumor growth in APC-mutated HT-29 cells and its xenograft mouse model, respectively, by elevating the expression of c-Myc, and β-catenin [226].